Cite
HARVARD Citation
Mehdi, D. et al. (n.d.). APL-2, a complement C3 inhibitor, may potentially reduce both intravascular and extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. Molecular immunology. pp. 115-. [Online].